YU Shuang, WANG Hu
2021, 29(2): 381.
To investigate the expression and the clinical significance of serum intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), and tumor necrosis factor-α (TNF-α) of women with intrahepatic cholestasis of pregnancy (ICP). Methods: 38 pregnant women with severe ICP were selected in group A, 62 pregnant women with mild ICP were selected in group B, and 30 normal pregnant women were selected in group C. The levels of the sICAM-1, sVCAM-1, TNF-α, and blood lipids of the women in the three groups were detected. Correlation analysis was performed, and the value of sICAM-1 level, sVCAM-1 level, or TNF-α level for diagnosing ICP was evaluated by ROC curve. Results: The serum levels of sICAM-1, sVCAM-1 and TNF-α of the women in group A and group B were significant higher than those of the women in group C, and those of the women in group A were significant higher than those of the women in group B (P<0.05). Pearson correlation analysis showed that the serum levels of sICAM-1, sVCAM-1 and TNF-αof the women with ICP were positively correlated with their total cholesterol, triglyceride, and low density lipoprotein levels, but were negatively correlated with their high density lipoprotein level (all P<0.05). ROC curve analysis showed that the area under the curve of the sICAM-1 level, sVCAM-1 level, or TNF-αlevel for diagnosing ICP was 0.838 (95%CI: 0.769-0.908), 0.831 (95%CI: 0.747-0.915), and 0.832 (95%CI: 0.759-0.905), respectively. The sensitivity of the sICAM-1 level, sVCAM-1 level, or TNF-αlevel for diagnosing ICP was 79.4%, 78.6%, and 77.2%, respectively. And the specificity of the sICAM-1 level, sVCAM-1 level, or TNF-αlevel for diagnosing ICP was 79.6%, 80.1%, and 82.3%, respectively. The area under the curve of the sICAM-1 level, sVCAM-1 level, or TNF-αlevel for diagnosing severe ICP was 0.798 (95%CI: 0.711-0.884), 0.751 (95%CI: 0.645-0.857), and 0.771 (95%CI: 0.676-0.866), respectively. The sensitivity of the sICAM-1 level, sVCAM-1 level, or TNF-αlevel for diagnosing severe ICP was 80.1%, 81.6%, and 75.4%, respectively. And the specificity of the sICAM-1 level, sVCAM-1 level, or TNF-αlevel for diagnosing severe ICP was 75.8%, 72.4%, and 82.5%, respectively. Conclusion: The abnormal expression of ICAM-1, VCAM-1 and TNF-α of the pregnant women may play an important role in the development of ICP, which can be used as assistant factors for clinical diagnosis of ICP.